Other analysts also recently issued research reports about the company. Royal Bank of Canada lowered their target price on Bausch Health Companies from $32.00 to $21.00 and set an outperform rating on the stock in a research report on Monday. Bank of America reduced their price objective on Bausch Health Companies from $25.00 to $12.00 in a report on Wednesday. BMO Capital Markets cut their price target on Bausch Health Companies from $26.00 to $15.00 in a research note on Wednesday. Finally, TheStreet cut Bausch Health Companies from a c- rating to a d+ rating in a research note on Monday, March 28th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of Buy and an average target price of $21.60.
BHC opened at $10.13 on Wednesday. The business’s 50-day moving average price is $21.32 and its two-hundred day moving average price is $24.24. Bausch Health Companies has a 1 year low of $7.80 and a 1 year high of $32.54. The company has a market capitalization of $3.66 billion, a price-to-earnings ratio of -3.81, a P/E/G ratio of 0.31 and a beta of 1.62.
In other Bausch Health Companies news, insider Joseph F. Gordon sold 6,338 shares of the company’s stock in a transaction on Tuesday, March 1st. The shares were sold at an average price of $23.82, for a total transaction of $150,971.16. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Robert Spurr sold 4,846 shares of the company’s stock in a transaction on Tuesday, March 15th. The shares were sold at an average price of $22.20, for a total transaction of $107,581.20. The disclosure for this sale can be found here. Insiders sold 16,668 shares of company stock valued at $378,570 over the last 90 days. 13.75% of the stock is currently owned by company insiders.
A number of institutional investors and hedge funds have recently modified their holdings of the business. Snider Financial Group boosted its position in Bausch Health Companies by 4.1% during the fourth quarter. Snider Financial Group now owns 10,868 shares of the company’s stock valued at $302,000 after acquiring an additional 431 shares during the last quarter. Glassman Wealth Services boosted its position in Bausch Health Companies by 71.4% during the fourth quarter. Glassman Wealth Services now owns 1,152 shares of the company’s stock valued at $32,000 after acquiring an additional 480 shares during the last quarter. First Manhattan Co. boosted its position in Bausch Health Companies by 11.1% during the third quarter. First Manhattan Co. now owns 5,000 shares of the company’s stock valued at $139,000 after acquiring an additional 500 shares during the last quarter. Mariner LLC boosted its position in Bausch Health Companies by 3.2% during the third quarter. Mariner LLC now owns 20,462 shares of the company’s stock valued at $570,000 after acquiring an additional 643 shares during the last quarter. Finally, IFP Advisors Inc boosted its position in shares of Bausch Health Companies by 7.3% during the 4th quarter. IFP Advisors Inc now owns 9,559 shares of the company’s stock worth $264,000 after purchasing an additional 651 shares in the last quarter. 73.38% of the stock is currently owned by institutional investors and hedge funds.
About Bausch Health Companies (Get Rating)
Bausch Health Companies Inc, together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.
- Get a free copy of the StockNews.com research report on Bausch Health Companies (BHC)
- Corning Stock is a Technology Value Play
- Wolverine Worldwide Is Ready To Rebound
- Anheuser-Busch InBev May Need One More Quarter to Confirm a Buy Signal
- Wendy’s Growth Story Has Come To An End
- Can Six Flags(SIX) or Cedar Fair (FUN) Give Investors a Thrill Later This Year?
Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.